Free Trial

Humacyte (HUMA) Earnings Date, Estimates & Call Transcripts

Humacyte logo
$2.53 +0.13 (+5.42%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.52 -0.01 (-0.40%)
As of 05/23/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Humacyte Earnings Summary

Humacyte released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.10, which topped analysts' consensus estimates of -$0.19 by $0.09. Quarterly revenue was reported to be $0.52 million, above analyst estimates of $0.46 million. With a trailing EPS of -$0.69, Humacyte's earnings are expected to grow next year, from ($1.27) to ($0.83) per share.

Upcoming Q2
Earnings Date
Aug. 12Before Market OpensEstimated
Consensus EPS
(May. 13)
-$0.19
Actual EPS
(May. 13)
-$0.10 Beat By $0.09
Actual Revenue
(May. 13)
$0.52M

Q1 2025 Earnings Resources

HUMA Upcoming Earnings

Humacyte's next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules.

Get Humacyte Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Humacyte and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

HUMA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HUMA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Humacyte Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20251-$0.14-$0.14-$0.14
Q3 20251-$0.13-$0.13-$0.13
Q4 20251-$0.12-$0.12-$0.12

Humacyte Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/12/2025
(Estimated)
--------
5/13/2025Q1 2025-$0.19-$0.10+$0.09$0.28$0.46M$0.52M
3/28/2025Q4 2024-$0.23-$0.16+$0.07-$0.16$0.64M$7.23M
11/8/2024Q3 2024-$0.25-$0.33 -$0.08-$0.33--
8/13/2024Q2 2024-$0.23-$0.27 -$0.04-$0.06--
5/10/2024Q1 2024-$0.23-$0.29 -$0.06-$0.29--
3/22/2024Q4 2023-$0.25-$0.24+$0.01-$0.24$0.10M-
11/9/2023Q3 2023-$0.25-$0.25--$0.25--
8/14/2023Q2 2023-$0.22-$0.22--$0.22$0.10M-

Humacyte Earnings - Frequently Asked Questions

Humacyte has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on HUMA's earnings history.

In the previous quarter, Humacyte (NASDAQ:HUMA) reported ($0.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.19) by $0.09. Learn more on analysts' earnings estimate vs. HUMA's actual earnings.

The conference call for Humacyte's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Humacyte's latest earnings report can be read online.
Read Transcript

Humacyte's earnings report can be found in their filing with the SEC.
View SEC filing

Humacyte (NASDAQ:HUMA) has a recorded annual revenue of $517,000.00.

Humacyte (NASDAQ:HUMA) has a recorded net income of -$110.78 million. HUMA has generated -$0.69 earnings per share over the last four quarters.

Humacyte's earnings are expected to grow from ($1.27) per share to ($0.83) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:HUMA) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners